Mallinckrodt invests $100M in its BioVectra CDMO
admin 6th March 2019 Uncategorised 0The Canadian operations plant where Mallinckrodt makes the API for its controversial—and pricey—H.P. Acthar Gel is expanding and getting some Canadian tax dollars to help with the expense.
More: Mallinckrodt invests 0M in its BioVectra CDMO
Source: fierce